Immunohistochemistry of cytokeratins 7, 8, 17, 18, and 19, and GLUT-1 aids differentiation of desmoplastic malignant mesothelioma from fibrous pleuritis. 2013/05
2.
原著
Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation. 2013/05
3.
症例報告
肝細胞癌術後脾転移の1切除例 2013/07
4.
原著
CD146 and insulin-like growth factor 2 mRNA-binding protein 3 predict prognosis of asbestos-induced rat mesothelioma. 2013/08
5.
原著
Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. 2013/08
6.
症例報告
Malignant poyentialを有した巨大肝欠陥筋脂肪腫の1例 2014/02
7.
症例報告
Medical Pictures 肺癌との鑑別を要した胸部デスモイド型線維腫症 2014/02
8.
原著
p53-Dependent suppression of genome instability in germ cells. 2014/02
9.
症例報告
混合型肝癌と肝細胞癌の同時性重複癌の1切除例 2014/02
10.
原著
Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. 2014/03
11.
症例報告
膀胱憩室内に発生した小細胞癌の1例 2014/03
12.
症例報告
直腸癌に併存した肝炎症性偽腫瘍の1例 2014/04
13.
原著
Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. 2014/06
14.
原著
Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. 2014/10
15.
原著
Exposure to High Doses of Lipopolysaccharide during Ovalbumin Sensitization Prevents the Development of Allergic Th2 Responses to a Dietary Antigen. 2014/10
16.
原著
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). 2014/12
17.
原著
肺癌との鑑別を要した胸部デスモイド型線維腫症 2014/12
18.
原著
LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. 2015/01
19.
原著
Biallelic germline and somatic mutations in malignant mesothelioma: Multiple mutations in transcription regulators including mSWI/SNF genes. 2015/02
20.
原著
p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer. 2015/06
21.
症例報告
CA19-9産生脾嚢胞に対して腹腔鏡下天蓋切除術を施行した1例 2015/08
22.
原著
Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level. 2015/08
Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue. 2015/11
25.
原著
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial) 2015/11
Expression of CD44 variant isoforms, CD44v3 and CD44v6, are associated with prognosis in nasopharyngeal carcinoma. 2016/09
31.
原著
Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. 2016/09
32.
症例報告
Pemetrexed for epithelioid haemangioendothelioma of the pleura. 2016/09
33.
原著
Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations. 2016/09
34.
原著
BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests. 2016/10
35.
原著
Polaprezinc protects normal intestinal epithelium against exposure to ionizing radiation in mice 2016/10
36.
原著
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. 2016/11
37.
症例報告
A case of atypical type A thymoma variant. 2016/12
38.
原著
Targeted Inactivation of DNA Photolyase Genes in Medaka Fish (Oryzias latipes). 2017/01
39.
原著
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry. 2017/02
40.
原著
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. 2017/02
41.
症例報告
遠位胆管腺扁平上皮癌の1切除例 2017/04
42.
原著
Pravastatin reduces radiation-induced damage in normal tissues. 2017/05
43.
原著
Regnase-1 Maintains Iron Homeostasis via the Degradation of Transferrin Receptor 1 and Prolyl-Hydroxylase-Domain-Containing Protein 3 mRNAs. 2017/05
44.
原著
The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis. 2017/09
45.
症例報告
潰瘍性大腸炎に併発した神経内分泌細胞癌の2例 2017/10
46.
症例報告
Hepatic pseudolymphoma with fluorodeoxyglucose uptake on positron emission tomography 2017/12
47.
原著
Regnase-1 and Roquin Nonredundantly Regulate Th1 Differentiation Causing Cardiac Inflammation and Fibrosis. 2017/12
48.
原著
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. 2018/01
49.
原著
Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer. 2018/01
50.
原著
The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer. 2018/03
51.
原著
Pulmonary Regnase-1 orchestrates the interplay of epithelium and adaptive immune systems to protect against pneumonia. 2018/07
52.
原著
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis. 2018/11
53.
原著
Integrative Molecular Characterization of Malignant Pleural Mesothelioma. 2018/12
54.
総説
Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. 2019/01
55.
原著
Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma. 2019/01
56.
症例報告
十二指腸に3ヶ所穿破した膵管内乳頭粘液性腺癌の1切除例 2019/03
57.
原著
Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma. 2019/07
58.
原著
The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy. 2019/11
59.
総説
早期中皮腫と中皮腫の新たな診断ツールとしての遺伝子異常 2019/11
60.
原著
Involvement of Rev1 in alkylating agent-induced loss of heterozygosity in Oryzias latipes. 2020/02
61.
原著
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma. 2020/08
62.
原著
Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma. 2020/09
63.
原著
Utility of highly expressed EZH2 in pleural effusion cytology for the diagnosis of mesothelioma. 2020/10
64.
症例報告
Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years. 2020/12
Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening. 2021/01
67.
原著
Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. 2021/03
68.
原著
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1. 2021/03
69.
原著
Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma. 2021/07
70.
原著
Short 57 kb CDKN2A FISH probe effectively detects short homozygous deletion of the 9p21 locus in malignant pleural mesothelioma. 2021/12
71.
原著
Enhancement of Regnase-1 expression with stem loop-targeting antisense oligonucleotides alleviates inflammatory diseases. 2022/05
72.
原著
Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features. 2022/06
73.
原著
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
74.
原著
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages. 2022/09
75.
原著
Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study. 2022/11
Pathology of Mesothelioma, Subtypes, and Rare Variants: What Is the Role of Immunohistochemical Markers in Differential Diagnosis?, Malignant Pleural Mesothelioma Advances in Pathogenesis, Diagnosis, and Treatments 2021/02
Association of activation of mTOR and MAPK signal pathway is associated with prolonged survival in parient with malignant pleural mesothelioma (ポスター,一般) 2014/05/30
36.
Blood tests in malignant pleural mesothelioma (MPM). (ポスター,一般) 2014/05/30
Diagnostic total parietal pleurectomy for pathologically-undetermined radiological/thoracoscopis TO malignant pleural mesothelioma. (ポスター,一般) 2014/10/22
44.
Early results of consecutive 27 patients who underwent pleurectomy / decortication for malignant pleutral mesothelioma (ポスター,一般) 2014/10/22
45.
The incidence and risk factors of part site seeding in MPM patients undergoing radical surgery (ポスター,一般) 2014/10/22
46.
CD146 expression is associated with prognosis of malignant mesothelioma (ポスター,一般) 2014/10/23
47.
Small cell mesothelioma undergone multimodality therapy, report of a case (ポスター,一般) 2014/10/23
48.
The pivotal role of anti-angiogenic activity in the in vivo antitumor effects of type I interferon. (ポスター) 2014/11
BAP1 immunostaining and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2016/05/29
99.
Clinial, Cytological, and Molecular biological approaches to the diagnosis of early mesothelopma (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2016/05/29
100.
Utility of liquid-based cytology in the diagnosis of malignant pleural mesothelioma (ポスター,一般) 2016/05/29
101.
Cytomorphological significance in diagnosing malignant mesothelioma in serous effusions (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2016/06/01